Patents by Inventor Mark E. Larkin

Mark E. Larkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6906709
    Abstract: A method of visualizing the impact of security flaws or breaches in a network. A 3-D visualization tool that simulates 3-D space on a monitor interfaces with a security database which relationally associates security events with the network elements affected thereby. The security events are visually depicted in a first section of simulated 3-D space and the network elements are depicted in a second section of simulated 3-D space. Relationship lines are drawn between displayed categories of security events and the displayed network elements in order to aid an analyst to visualize the impact of security breaches on the organization. Various other properties of the network elements may also be displayed such as the role of the network device within the organization, and the business functions of the organization.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: June 14, 2005
    Assignee: Applied Visions, Inc.
    Inventors: Mark E. Larkin, Anita D. D'Amico
  • Patent number: 5961497
    Abstract: A connecting system is provided with a connector adapted to be mounted to the end of a conduit for removably engaging a blunt cannula to establish fluid communication between the conduit and cannula. The connector has a housing which defines a passage for communicating with the conduit and which defines an opening to the passage. The housing also defines a generally frustoconical seating surface which decreases in diameter in the direction toward the opening. A generally fluid-impervious, resilient seal is retained within the housing passage against the seating surface. The seal defines a slit which can accommodate penetration by the blunt cannula and which can reseal upon withdrawal of the blunt cannula.
    Type: Grant
    Filed: October 29, 1997
    Date of Patent: October 5, 1999
    Assignee: Abbott Laboratories
    Inventor: Mark E. Larkin
  • Patent number: 5951863
    Abstract: Medical drug formulation and delivery system includes a reverse osmosis device for purifying water from a source comprising a housing having an inlet for passage of water from the source, a first outlet for passage of purified water from the housing and a second outlet for passage of waste water remaining after purification. A first reverse osmosis multilayer assembly is disposed within the housing in fluid communication with the inlet for purification of at least a first portion of the water from the source. Water treatment chemicals can be positioned in a core about which the first reserve osmosis multilayer assembly is wound. The treatment chemicals are in fluid communication with the first reverse osmosis multilayer assembly to receive the first purified portion of water and for removal of at least chemical contaminants therefrom.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: September 14, 1999
    Assignee: Abbott Laboratories
    Inventors: Robert J. Kruger, Warren P Frederick, R. Hayes Helgren, Mark E. Larkin, Joaquin Mayoral, Brad A. Schmolesky, Roman W Siczek, Kenneth J. Timmons
  • Patent number: 5743886
    Abstract: A system for the sequential and repetitive aspiration and injection of fluid. The system includes a syringe having an internal volume, a piston to vary the internal volume and a chamber divider for separating the internal volume into proximal and distal reservoirs. The chamber divider is moveable along the chamber and is positioned adjacent the distal end of the chamber prior to withdrawal of fluid into the syringe. The proximal reservoir has a maximum displacement volume for receiving fluid. A flow channel provides flow between the proximal and distal reservoirs and a valve disables and enables flow therethrough. A tensile element links the piston and the chamber divider so that after the piston is moved and the proximal reservoir is filled with a first liquid, the chamber divider is pulled away from the distal end of the syringe to enlarge the distal reservoir and draw the blood into the distal reservoir.
    Type: Grant
    Filed: August 20, 1996
    Date of Patent: April 28, 1998
    Assignee: Lawrence A. Lynn
    Inventors: Lawrence A. Lynn, Mark E. Larkin
  • Patent number: 5643218
    Abstract: A syringe for the sequential withdrawal of a first liquid and a second liquid. The syringe has a barrel, a proximal piston moveable along the barrel to define a variable volume chamber intermediate the piston and the end of the barrel, and a distal chamber divider piston for separating the variable volume chamber into primary and secondary reservoirs. A flow channel is defined along the syringe for providing flow connection between the primary and secondary reservoirs. An element links the two pistons so that as the proximal piston is moved away from the distal piston, the first liquid enters the first reservoir and thereafter the second liquid enters the secondary reservoir.
    Type: Grant
    Filed: August 20, 1996
    Date of Patent: July 1, 1997
    Assignee: Lawrence A. Lynn
    Inventors: Lawrence A. Lynn, Mark E. Larkin
  • Patent number: 5549569
    Abstract: A system for the sequential and repetitive aspiration and injection of fluid. The system includes a syringe having an internal volume, a piston to vary the internal volume and a chamber divider for separating the internal volume into proximal and distal reservoirs. The chamber divider is moveable along the chamber and is positioned adjacent the distal end of the chamber prior to withdrawal of fluid into the syringe. The proximal reservoir has a maximum displacement volume for receiving fluid. A flow channel provides flow between the proximal and distal reservoirs and a valve disables and enables flow therethrough. A tensile element links the piston and the chamber divider so that after the piston is moved and the proximal reservoir is filled with a first liquid, the chamber divider is pulled away from the distal end of the syringe to enlarge the distal reservoir and draw the blood into the distal reservoir.
    Type: Grant
    Filed: March 30, 1995
    Date of Patent: August 27, 1996
    Assignee: Lawrence A. Lynn
    Inventors: Lawrence A. Lynn, Mark E. Larkin
  • Patent number: 5507733
    Abstract: A securable collar is used with two connectors to prevent the inadvertent disconnection of IV tubing sets. The securable collar includes a housing supported by one of the connectors, a radial flange extending from the housing, a collar having a frustum-shape, two notches that separate the collar into two longitudinal segments, a transition portion on the exterior of the collar, and a sliding annular locking ring. The locking ring slides on the collar from a small diameter portion over the transition portion to a larger diameter portion. The annular locking ring compresses the larger diameter portion to pivot the longitudinal segments radially inward at the radial flange to grip the second connector.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: April 16, 1996
    Assignee: Abbott Laboratories
    Inventors: Mark E. Larkin, David E. Kramer, Warren P. Frederick
  • Patent number: 5498338
    Abstract: Medical drug formulation and delivery system includes a reverse osmosis device for purifying water from a source comprising a housing having an inlet for passage of water from the source, a first outlet for passage of purified water from the housing and a second outlet for passage of waste water remaining after purification. A first reverse osmosis multilayer assembly is disposed within the housing in fluid communication with the inlet for purification of at least a first portion of the water from the source. Water treatment chemicals can be positioned in a core about which the first reserve osmosis multilayer assembly is wound. The treatment chemicals are in fluid communication with the first reverse osmosis multilayer assembly to receive the first purified portion of water and for removal of at least chemical contaminants therefrom.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: March 12, 1996
    Assignee: Abbott Laboratories
    Inventors: Robert J. Kruger, Warren P. Frederick, R. Hayes Helgren, Mark E. Larkin, Joaquin Mayoral, Brad A. Schmolesky, Roman W. Siczek, Kenneth J. Timmons
  • Patent number: 5437650
    Abstract: A securing collar is used in combination with two tubular flow connectors to prevent the inadvertent disconnection of I.V. tubing sets. The securing collar includes a housing supported by one of the connectors, a radial flange extending from the housing, a tubular collar having a outwardly splayed end, at least two notches that separates the splayed collar into at least two elongated segments, a transition portion on the exterior of the collar, and a sliding annular locking ring. The locking ring slides on the collar from the proximal end over the transition portion to the distal segments so that the annular locking ring forces the splayed and segmented distal portions radially inward to grip the second connector.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: August 1, 1995
    Assignee: Abbott Laboratories
    Inventors: Mark E. Larkin, Dvid E. Kramer, Warren P. Frederick
  • Patent number: 5405340
    Abstract: A self-threading securing apparatus is used in combination with two tubular flow connectors to prevent the inadvertent disconnection of I.V. tubing sets. The securing apparatus includes a hollow shroud surrounding an extending cannula. The inner surface of the shroud includes interior threads for self-threading engagement with the resilient rolled-over exterior surface portion of the reseal connector.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: April 11, 1995
    Assignee: Abbott Laboratories
    Inventors: Frank R. Fageol, Peter R. Kessenich, Mark E. Larkin
  • Patent number: 5352364
    Abstract: A reverse osmosis device for purifying water from a source comprising a housing having an inlet for passage of water from the source, a first outlet for passage of purified water from the housing and a second outlet for passage of waste water remaining after purification. A first reverse osmosis multilayer assembly is disposed within the housing in fluid communication with the inlet for purification of at least a first portion of the water from the source. Water treatment chemicals can be positioned in a core about which the first reserve osmosis multilayer assembly is wound. The treatment chemicals are in fluid communication with the first reverse osmosis multilayer assembly to receive the first purified portion of water and for removal of at least chemical contaminants therefrom. A second reverse osmosis multilayer assembly is also wound on the core and is in fluid communication with the water treatment chemicals to receive the chemically purified water for purification of at least a second portion thereof.
    Type: Grant
    Filed: December 15, 1992
    Date of Patent: October 4, 1994
    Assignee: Abbott Laboratories
    Inventors: Robert J. Kruger, Warren P. Frederick, Mark E. Larkin, Joaquin Mayoral, Sheldon M. Wecker
  • Patent number: 5328041
    Abstract: A stopper assembly for sealing the open end of a container and usable with a blunt entry device includes an elastomeric stopper having an annular flange portion, a hollow plug portion, and a thin diaphragm portion, the flange portion covering and abutting the open end of the container, the plug portion depending from the inner circumference of the flange portion and sealingly engaging the interior of the open end of the container, and the diaphragm portion spanning the center portion of the annular flange portion. A metal ferrule for securing the stopper to the container has an annular top portion and an annular skirt portion for engagement with the exterior of the container.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: July 12, 1994
    Assignee: Abbott Laboratories
    Inventors: William J. Hook, Mark E. Larkin
  • Patent number: 5312547
    Abstract: Medical drug formulation and delivery system includes a reverse osmosis device for purifying water from a source comprising a housing having an inlet for passage of water from the source, a first outlet for passage of purified water from the housing and a second outlet for passage of waste water remaining after purification. A first reverse osmosis multilayer assembly is disposed within the housing in fluid communication with the inlet for purification of at least a first portion of the water from the source. Water treatment chemicals can be positioned in a core about which the first reserve osmosis multilayer assembly is wound. The treatment chemicals are in fluid communication with the first reverse osmosis multilayer assembly to receive the first purified portion of water and for removal of at least chemical contaminants therefrom.
    Type: Grant
    Filed: March 4, 1992
    Date of Patent: May 17, 1994
    Assignee: Abbott Laboratories
    Inventors: Robert J. Kruger, Warren P. Frederick, William J. Hook, Mark E. Larkin, Joaquin Mayoral, Roman W. Siczek, Kenneth J. Timmons, Sheldon M. Wecker
  • Patent number: 5279571
    Abstract: An access site for a fluid delivery system is disclosed. The apparatus comprises a rigid, tubular housing having a stepped inlet end, an outlet end and a bore therebetween, the stepped inlet end having an initial larger diameter cavity than the bore. Within the inlet end is a solid resilient sealing member having a larger and smaller cross dimensional portion positioned within the corresponding portions of the cavity and bore. The resilient member includes an axially parallel perforation and at least one axially protruding sealing ring on the large cross dimensioned portion of the sealing member in contact with a shoulder of the housing. Also included is a means for securing the member in the housing such that the resilient member experiences axial compressive forces at all points of axial contact between the member and housing.
    Type: Grant
    Filed: March 3, 1993
    Date of Patent: January 18, 1994
    Assignee: Abbott Laboratories
    Inventor: Mark E. Larkin
  • Patent number: 5248306
    Abstract: A retainer is used in combination with two tubular flow connectors to prevent the inadvertent disconnection of I.V. tubing sets. The retainer includes at least one open collar having a flexible opening so as to be radially and securely attachable adjacent to an increased diameter portion on a tubing connector. A pair of parallel straps connects the collar with an axially pivotable joint so as to facilitates easy manipulation and engagement of the retainer.
    Type: Grant
    Filed: August 25, 1992
    Date of Patent: September 28, 1993
    Assignee: Abbott Laboratories
    Inventors: John C. Clark, William J. Hook, Mark E. Larkin
  • Patent number: 5215538
    Abstract: An in-line valve for a medical tubing set has a tubular member characterized by an internal annular valve seat and a generally circular rubber-like valve member disposed transversely of the tubular member with its edges fixed relative thereto and with a central portion thereof tensioned into seating engagement against the annular valve seat whereby to normally close the in-line valve. Elements on the valve member are engageable by a connector as same is assembled to the tubular member to move the valve member off of the valve seat whereby to automatically open the in-line valve upon assembly of a connector thereto.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: June 1, 1993
    Assignee: Abbott Laboratories
    Inventor: Mark E. Larkin
  • Patent number: 5190525
    Abstract: A drug infusion manifold for controlling the infusion of drugs and/or other solutions into an intravenous patient feed line. The manifold includes a housing defining an elongated in-line flow channel that communicates at one end with a carrier fluid inlet line and at the other end with the patient feed line. A plurality of spaced apart drug inlet openings are formed in the housing in communication with the flow channel. Each of the inlet openings is provided with a check valve assembly that includes a valve member defining an inlet socket portion and a valve stem portion that extends into the flow channel. The valve stem portion has a cylindrical side wall that defines an inlet passage that communicates with the socket portion. A plurality of lateral inlet ports extend through the side wall. An elastic sleeve member is received about the valve stem portion in covering relationship with the inlet ports. The valve stem portion is in-line with the flow of carrier fluid through the flow channel.
    Type: Grant
    Filed: December 31, 1991
    Date of Patent: March 2, 1993
    Assignee: Abbott Laboratories
    Inventors: Timothy J. Oswald, Lois L. Caron, Mark E. Larkin, William L. Rudzena, Edward S. Tripp
  • Patent number: 5171214
    Abstract: A drug storage and delivery system that includes a drug containing vial assembly, a syringe assembly, and an adapter assembly for attaching the vial assembly to the adapter assembly. The vial assembly includes a vial that is provided with a pierceable stopper and a skirt member that circumscribes the outside of the vial. The syringe assembly includes a cannula extending longitudinally therethrough. The adapter assembly attaches the vial assembly to the syringe assembly in a manner that permits communication between the interior of the vial and the cannula extending through the syringe. The system also permits attachment of the syringe assembly to a container filled with a diluent and means for delivering the diluent into the vial assembly and subsequently directing the mixed solution back into the container.
    Type: Grant
    Filed: December 26, 1990
    Date of Patent: December 15, 1992
    Assignee: Abbott Laboratories
    Inventors: Chris M. Kolber, Peter L. Bryant, Mark E. Larkin, Peter J. Karas, John S. Ziegler
  • Patent number: 5151090
    Abstract: A needle guard for an additive-type syringe includes a sidewall which extends beyond the needle point. The sidewall is joined to the syringe housing by spin welding or sonic welding an annular flange that extends axially rearward from the needle guard to contact the front wall of the housing. The needle guard also includes an intermediate circumferential flange and a centering and guiding member that frictionally slides in the needle guard.
    Type: Grant
    Filed: October 19, 1990
    Date of Patent: September 29, 1992
    Assignee: Abbott Laboratories
    Inventors: Robert J. Best, Mark E. Larkin, Juergen H. Zaha
  • Patent number: 5137524
    Abstract: An universal medical connector for manually connecting a first fluid conveying conduit in fluid connection with a patient's vasculature and having a junction terminal with a septum at an end thereof to a second fluid conduit for administration of fluid to a patient. The connector is formed of two elements. The first element defines an integral needle hub, to which a needle is mounted, a base extending from the hub, and fingers extending from the base. The second locking element includes a collar with a support and bars extending therefrom so as to be manually slidable along the first element in the direction the needle extends between a retracted and a locking position in which the connector locks onto a junction terminal and the septum penetrated by the needle. The fingers flex at a flexing line or joint or in a flexure region covered by the bars in the retracted position. Detents are provided on the base and on a detent carrier formed by slots extending into the collar.
    Type: Grant
    Filed: April 17, 1990
    Date of Patent: August 11, 1992
    Assignee: Lawrence A. Lynn
    Inventors: Lawrence A. Lynn, Mark E. Larkin